These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22751762)

  • 21. Intracerebral hemorrhage: Pick your poison.
    Michota F
    Cleve Clin J Med; 2010 Nov; 77(11):743-6. PubMed ID: 21048048
    [No Abstract]   [Full Text] [Related]  

  • 22. Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolism.
    Acharjee S; Cannon CP
    Crit Pathw Cardiol; 2011 Jun; 10(2):84-6. PubMed ID: 21988948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dabigatran in patients with nonvalvular atrial fibrillation.
    Gage L
    J Am Coll Cardiol; 2011 Jul; 58(5):551; author reply 551. PubMed ID: 21777759
    [No Abstract]   [Full Text] [Related]  

  • 24. [New anticoagulants, new emergencies?].
    Djalali S
    Praxis (Bern 1994); 2013 Jul; 102(15):945-6. PubMed ID: 23876694
    [No Abstract]   [Full Text] [Related]  

  • 25. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
    Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dabigatran, bleeding, and the regulators.
    Moore TJ; Cohen MR; Mattison DR
    BMJ; 2014 Jul; 349():g4517. PubMed ID: 25056265
    [No Abstract]   [Full Text] [Related]  

  • 27. Place of dabigatran in contemporary pharmacotherapy.
    Gums JG
    Pharmacotherapy; 2011 Apr; 31(4):335-7. PubMed ID: 21449622
    [No Abstract]   [Full Text] [Related]  

  • 28. Direct thrombin inhibitors for the treatment of venous thromboembolism: analysis of the Dabigatran versus Warfarin clinical trial.
    Liem TK; Deloughery TG
    Semin Vasc Surg; 2011 Sep; 24(3):157-61. PubMed ID: 22153026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dabigatran (Pradaxa).
    Comin J; Kallmes DF
    AJNR Am J Neuroradiol; 2012 Mar; 33(3):426-8. PubMed ID: 22345499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
    Welzel D; Hull R; Fareed J
    Int Angiol; 2011 Jun; 30(3):199-211. PubMed ID: 21617603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dabigatran: life-threatening bleeding.
    Prescrire Int; 2013 Feb; 22(135):41-3. PubMed ID: 23444501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The trouble with dabigatran.
    Charlton B; Redberg R
    BMJ; 2014 Jul; 349():g4681. PubMed ID: 25055830
    [No Abstract]   [Full Text] [Related]  

  • 33. Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA).
    Pengo V; Crippa L; Falanga A; Finazzi G; Marongiu F; Palareti G; Poli D; Testa S; Tiraferri E; Tosetto A; Tripodi A; Manotti C;
    Thromb Haemost; 2011 Nov; 106(5):868-76. PubMed ID: 21946939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New anticoagulants: "efficacy and safety" or "efficacy or safety"].
    Pernod G
    J Mal Vasc; 2011 Dec; 36(6):337-8. PubMed ID: 21907510
    [No Abstract]   [Full Text] [Related]  

  • 35. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of anticoagulation.
    Bilen O; Teruya J
    Dis Mon; 2012 Aug; 58(8):440-7. PubMed ID: 22818558
    [No Abstract]   [Full Text] [Related]  

  • 37. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
    Uchiyama S; Ibayashi S; Matsumoto M; Nagao T; Nagata K; Nakagawara J; Tanahashi N; Tanaka K; Toyoda K; Yasaka M
    J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):165-73. PubMed ID: 22440950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New anticoagulants--are we prepared?].
    Pawlikowska Z; Szponar J
    Przegl Lek; 2012; 69(8):483-5. PubMed ID: 23243913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War?
    Diener HC; Eikelboom J; Granger CB; Hacke W
    Int J Stroke; 2012 Feb; 7(2):139-41. PubMed ID: 22264366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights from the dabigatran versus warfarin trial in patients with venous thromboembolism (the RE-COVER trial).
    Prandoni P; Taher A
    Expert Opin Pharmacother; 2010 Apr; 11(6):1035-7. PubMed ID: 20307227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.